Mitsubishi UFJ Asset Management (UK)’s West Pharmaceutical WST Stock Holding History

Mitsubishi UFJ Asset Management (UK)’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.26M	Buy	3,500 +2,000	+133%	+$611K	0.58%	55
2026 Q1	$376K	Buy	+1,500	New	+$373K	0.19%	83
2025 Q1	–	Sell	-3,500	Closed	-$1.15M	–	127
2024 Q4	$1.15M	Sell	3,500 -2,500	-42%	-$787K	0.51%	52
2024 Q3	$1.8M	Buy	6,000 +4,000	+200%	+$1.22M	0.93%	26
2024 Q2	$659K	Hold	2,000	–	–	0.34%	71
2024 Q1	$791K	Sell	2,000 -2,000	-50%	-$740K	0.4%	64
2023 Q4	$1.41M	Buy	4,000 +2,000	+100%	+$708K	0.77%	34
2023 Q3	$750K	Buy	2,000 +1,000	+100%	+$387K	0.53%	56
2023 Q2	$382K	Sell	1,000 -3,000	-75%	-$1.07M	0.25%	86
2023 Q1	$1.39M	Buy	+4,000	New	+$1.17M	0.9%	42
2022 Q4	–	Sell	-10,500	Closed	-$2.58M	–	83
2022 Q3	$2.58M	Hold	10,500	–	–	2%	14
2022 Q2	$3.17M	Hold	10,500	–	–	1.83%	15
2022 Q1	$4.31M	Hold	10,500	–	–	1.94%	8
2021 Q4	$4.92M	Hold	10,500	–	–	2.1%	10
2021 Q3	$4.46M	Hold	10,500	–	–	1.88%	14
2021 Q2	$3.77M	Buy	10,500 +3,000	+40%	+$991K	1.63%	15
2021 Q1	$2.11M	Buy	+7,500	New	+$2.15M	0.93%	40
2020 Q4	–	Sell	-3,100	Closed	-$852K	–	86
2020 Q3	$852K	Sell	3,100 -1,000	-24%	-$265K	0.42%	63
2020 Q2	$931K	Sell	4,100 -2,900	-41%	-$570K	0.5%	60
2020 Q1	$1.06M	Buy	+7,000	New	+$1.08M	0.8%	44

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Mitsubishi UFJ Asset Management (UK)'s WST Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management (UK) increased its West Pharmaceutical (WST) stake by 133% in Q2 2026, buying an estimated $611K and bringing the position to 3,500 shares worth $1.26M. The position accounts for 0.58% of the portfolio, ranked #55.

Mitsubishi UFJ Asset Management (UK) first reported a position in WST in Q1 2020 and has held it in 20 quarters since. The position peaked at $4.92M in Q4 2021. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Mitsubishi UFJ Asset Management (UK) held 3,500 shares of West Pharmaceutical worth $1.26M as of Q2 2026.
Mitsubishi UFJ Asset Management (UK) bought 2,000 West Pharmaceutical shares in Q2 2026, an estimated $611K.
West Pharmaceutical made up 0.58% of Mitsubishi UFJ Asset Management (UK)'s portfolio in Q2 2026, its #55 holding.
Mitsubishi UFJ Asset Management (UK) first reported a position in West Pharmaceutical in Q1 2020 and has held it in 20 quarters since.
Mitsubishi UFJ Asset Management (UK)'s West Pharmaceutical position peaked at $4.92M in Q4 2021.
830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Mitsubishi UFJ Asset Management (UK)'s 13F filing for Q2 2026, filed 28 Jul 2026.